Compare LXRX & RWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LXRX | RWT |
|---|---|---|
| Founded | 1995 | 1994 |
| Country | United States | United States |
| Employees | N/A | 351 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 660.9M | 707.5M |
| IPO Year | 2000 | N/A |
| Metric | LXRX | RWT |
|---|---|---|
| Price | $1.68 | $5.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $4.15 | ★ $6.82 |
| AVG Volume (30 Days) | ★ 2.1M | 1.2M |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 12.63% |
| EPS Growth | ★ 77.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $49,803,000.00 | N/A |
| Revenue This Year | N/A | $26.59 |
| Revenue Next Year | N/A | $22.21 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 60.24 | N/A |
| 52 Week Low | $0.51 | $5.00 |
| 52 Week High | $1.95 | $6.97 |
| Indicator | LXRX | RWT |
|---|---|---|
| Relative Strength Index (RSI) | 47.92 | 45.27 |
| Support Level | $1.47 | $5.39 |
| Resistance Level | $1.81 | $5.74 |
| Average True Range (ATR) | 0.10 | 0.14 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 31.25 | 13.54 |
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.